首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human APP Abeta Recombinant Antibody(Bapineuzumab)

Anti-Human APP Abeta Recombinant Antibody(Bapineuzumab)

产品编号

YR1164

别名

科研级 Bapineuzumab ( 巴匹组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Bapineuzumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Bapineuzumab ( 巴匹组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Bapineuzumab
Catalog NumberYR1164
Molecular NameBapineuzumab
CAS Number648895-38-9
TargetAPP Abeta[Homo sapiens]
Antibody IsotypeIgG1
ClonityMonoclonal
Size1mg, 5mg
Concentration1mg/ml
Purity>95% as determined by SDS-PAGE
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.5
Shipping ConditionShipped on ice packs.
BackgroundBapineuzumab (nicknamed "bapi") is a humanized monoclonal antibody that acts on the nervous system and may have potential therapeutic value for the treatment of Alzheimer's disease and possibly glaucoma. However, in 2012 it failed to produce significant cognitive improvements in patients in two major trials, despite lowering key biomarkers of AD, amyloid brain plaque and hyperphosphorylated tau protein in CSF.
HostMouse
ApplicationWB, FuncS, IF, Neut, ELISA, FCM, IP
RemarksThis product is for research use only.

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价